Meeting
2014 ASCO Annual Meeting
Cisplatin versus cetuximab plus concomitant radiotherapy in locally advanced head and neck cancer: A meta-analysis of published trials.
Authors
Sandro Barni
Department of Medical Oncology, Treviglio and Caravaggio Hospital, Treviglio, Italy
Sandro Barni , Andrea Coinu , Karen Borgonovo , Mary Cabiddu , Marco Cremonesi , Fausto Petrelli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 6014)
DOI
10.1200/jco.2014.32.15_suppl.6014
Abstract #
6014
Poster Bd #
29
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Association of the addition of cetuximab to preoperative chemoradiotherapy (CRT) for locally advanced esophageal squamous cell carcinoma (SqCC) with rate of long term survival: Mature results of a prospective phase Ib/II trial.
First Author: Baruch Brenner
Poster
2016 Gastrointestinal Cancers Symposium
The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.
First Author: Hung-Yang Kuo
Poster
2011 ASCO Annual Meeting
Concomitant chemoradiation in locally advanced head and neck squamous cell carcinoma: A literature-based meta-analysis on the platinum concomitant chemotherapy.
First Author: M. G. Ghi
Poster
2011 ASCO Annual Meeting
Concurrent chemoradiotherapy with or without induction chemotherapy for locally advanced head and neck cancer.
First Author: J. J. Caudell